Just Say Know: A Review of Illicit Substances

This course reviews Multiple Sclerosis. It can be taken by anyone interested in the topic but offers continuing education (CE) credit for United States healthcare practitioners in nursing, pharmacy, mental health, and more. The field of Multiple Sclerosis (MS) is ever-changing, with new targets and biomarkers being discovered each year. It can be challenging to stay up to date on newly approved agents given the many different components that play a role in the treatment of Multiple Sclerosis. This course will review the newest FDA-approved Multiple Sclerosis treatment agents, focusing on their efficacy and safety features. It will provide clinicians with critical drug and patient characteristics essential for appropriate treatment selection and recommendations. By the end of this activity, you will have a thorough understanding of the latest advancements in MS treatment, enabling you to make informed decisions and provide the best care for your patients. Enhancing your knowledge of the latest FDA-approved therapies ensures you are equipped to manage the complexities of Multiple Sclerosis effectively. Join us in this comprehensive review designed to keep you at the forefront of MS treatment advancements. This course will empower you with the insights needed to optimize patient outcomes in Multiple Sclerosis care.